{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:36:03Z","timestamp":1773693363678,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002847"],"award-info":[{"award-number":["82002847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020T130447"],"award-info":[{"award-number":["2020T130447"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Excellent Youth Foundation of Sichuan Scientific Committee Grant in China","award":["2019JDJQ008"],"award-info":[{"award-number":["2019JDJQ008"]}]},{"name":"National Major Scientific and Technological Special Project for \u201cSignificant New Drugs Development\u201d"},{"name":"Key Programs of Sichuan Scientific Committee Grant in China","award":["2020YFS0144"],"award-info":[{"award-number":["2020YFS0144"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1245\/s10434-021-09836-9","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T21:03:38Z","timestamp":1616360618000},"page":"6453-6463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient-Derived Tumor Xenografts Plus Ex Vivo Models Enable Drug Validation for Tenosynovial Giant Cell Tumors"],"prefix":"10.1245","volume":"28","author":[{"given":"Fan","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Tie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hou-Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia-Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Qi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,21]]},"reference":[{"issue":"2","key":"9836_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2017.75.8482","volume":"36","author":"MM Gounder","year":"2018","unstructured":"Gounder MM, Thomas DM, Tap WD. Locally aggressive connective tissue tumors. J Clin Oncol. 2018;36(2):202\u20139.","journal-title":"J Clin Oncol."},{"key":"9836_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejca.2019.11.013","volume":"127","author":"B Alman","year":"2020","unstructured":"Alman B, Attia S, Baumgarten C, et al. The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer (Oxford, England: 1990). 2020;127:96\u2013107.","journal-title":"Eur J Cancer (Oxford, England: 1990)."},{"issue":"6","key":"9836_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1470-2045(19)30100-7","volume":"20","author":"MJL Mastboom","year":"2019","unstructured":"Mastboom MJL, Palmerini E, Verspoor FGM, et al. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study. Lancet Oncol. 2019;20(6):877\u201386.","journal-title":"Lancet. Oncol."},{"issue":"4","key":"9836_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jso.23220","volume":"107","author":"L van der Heijden","year":"2013","unstructured":"van der Heijden L, Gibbons CL, Hassan AB, et al. A multidisciplinary approach to giant cell tumors of tendon sheath and synovium\u2014a critical appraisal of literature and treatment proposal. J Surg Oncol. 2013;107(4):433\u201345.","journal-title":"J Surg Oncol."},{"issue":"6","key":"9836_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/17453674.2017.1361126","volume":"88","author":"MJL Mastboom","year":"2017","unstructured":"Mastboom MJL, Verspoor FGM, Verschoor AJ, et al. Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop. 2017;88(6):688\u201394.","journal-title":"Acta Orthop."},{"issue":"9","key":"9836_CR6","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s11999.0000000000000102","volume":"476","author":"MJL Mastboom","year":"2018","unstructured":"Mastboom MJL, Verspoor FGM, Uittenbogaard D, et al. Tenosynovial giant cell tumors in children: a similar entity compared with adults. Clin Orthop Relat Res. 2018;476(9):1803\u201312.","journal-title":"Clin Orthop Relat Res."},{"key":"9836_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejca.2016.04.022","volume":"63","author":"EL Staals","year":"2016","unstructured":"Staals EL, Ferrari S, Donati DM, Palmerini E. Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives. Eur J Cancer (Oxford, England: 1990). 2016;63:34\u201340.","journal-title":"Eur J Cancer (Oxford, England: 1990)."},{"issue":"2","key":"9836_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11864-015-0385-x","volume":"17","author":"M Brahmi","year":"2016","unstructured":"Brahmi M, Vinceneux A, Cassier PA. Current systemic treatment options for tenosynovial giant cell tumor\/pigmented villonodular synovitis: targeting the CSF1\/CSF1R axis. Curr Treat Options Oncol. 2016;17(2):10.","journal-title":"Curr Treat Options Oncol."},{"issue":"7","key":"9836_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1302\/0301-620X.94B7.28927","volume":"94","author":"L van der Heijden","year":"2012","unstructured":"van der Heijden L, Gibbons CL, Dijkstra PD, et al. The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis). J Bone Joint Surg British volume. 2012;94(7):882\u20138.","journal-title":"J Bone Joint Surg. British volume."},{"issue":"6","key":"9836_CR10","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/cncr.26409","volume":"118","author":"PA Cassier","year":"2012","unstructured":"Cassier PA, Gelderblom H, Stacchiotti S, et al. Efficacy of imatinib mesylate for the treatment of locally advanced and\/or metastatic tenosynovial giant cell tumor\/pigmented villonodular synovitis. Cancer. 2012;118(6):1649\u201355.","journal-title":"Cancer."},{"issue":"6","key":"9836_CR11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/PAS.0b013e31802b86f8","volume":"31","author":"JS Cupp","year":"2007","unstructured":"Cupp JS, Miller MA, Montgomery KD, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007;31(6):970\u20136.","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"9836_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13577-020-00425-8","volume":"34","author":"R Noguchi","year":"2021","unstructured":"Noguchi R, Yoshimatsu Y, Ono T, et al. Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor. Human Cell. 2021;34(1):254\u20139.","journal-title":"Human Cell."},{"issue":"1","key":"9836_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","volume":"13","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13(1):4.","journal-title":"J Hematol Oncol."},{"issue":"1","key":"9836_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1245\/s10434-015-4425-3","volume":"23","author":"M Read","year":"2016","unstructured":"Read M, Liu D, Duong CP, et al. Intramuscular transplantation improves engraftment rates for esophageal patient-derived tumor xenografts. Ann Surg Oncol. 2016;23(1):305\u201311.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"9836_CR15","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1245\/s10434-016-5116-4","volume":"23","author":"TE Newhook","year":"2016","unstructured":"Newhook TE, Lindberg JM, Adair SJ, et al. Adjuvant trametinib delays the outgrowth of occult pancreatic cancer in a mouse model of patient-derived liver metastasis. Ann Surg Oncol. 2016;23(6):1993\u20132000.","journal-title":"Ann Surg Oncol."},{"key":"9836_CR16","doi-asserted-by":"publisher","first-page":"174528","DOI":"10.1155\/2010\/174528","volume":"2010","author":"H Cheng","year":"2010","unstructured":"Cheng H, Clarkson PW, Gao D, Pacheco M, Wang Y, Nielsen TO. Therapeutic antibodies targeting csf1 impede macrophage recruitment in a xenograft model of tenosynovial giant cell tumor. Sarcoma. 2010;2010:174528.","journal-title":"Sarcoma."},{"issue":"6","key":"9836_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41416-019-0672-6","volume":"122","author":"IR Powley","year":"2020","unstructured":"Powley IR, Patel M, Miles G, et al. Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Br J Cancer. 2020;122(6):735\u201344.","journal-title":"Br J Cancer."},{"issue":"1","key":"9836_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ygyno.2019.11.020","volume":"156","author":"A Collins","year":"2020","unstructured":"Collins A, Miles GJ, Wood J, MacFarlane M, Pritchard C, Moss E. Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer. Gynecol Oncol. 2020;156(1):251\u20139.","journal-title":"Gynecol Oncol."},{"issue":"10","key":"9836_CR19","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1093\/nar\/gkaa271","volume":"48","author":"A Bainbridge","year":"2020","unstructured":"Bainbridge A, Walker S, Smith J, et al. IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway. Nucleic Acids Res. 2020;48(10):5366\u201382.","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"9836_CR20","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.7150\/thno.34065","volume":"10","author":"X Yuan","year":"2020","unstructured":"Yuan X, Nie W, He Z, et al. Carbon black nanoparticles induce cell necrosis through lysosomal membrane permeabilization and cause subsequent inflammatory response. Theranostics. 2020;10(10):4589\u2013605.","journal-title":"Theranostics."},{"issue":"1","key":"9836_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41392-020-0115-0","volume":"5","author":"Y Tie","year":"2020","unstructured":"Tie Y, Zheng H, He Z, et al. Targeting folate receptor \u03b2 positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex. Signal Transduc Target Ther. 2020;5(1):6.","journal-title":"Signal Transduc Target Ther."},{"issue":"18","key":"9836_CR22","first-page":"4952","volume":"54","author":"YQ Wei","year":"1994","unstructured":"Wei YQ, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 1994;54(18):4952\u20137.","journal-title":"Cancer Res."},{"issue":"2","key":"9836_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejca.2014.11.001","volume":"51","author":"E Palmerini","year":"2015","unstructured":"Palmerini E, Staals EL, Maki RG, et al. Tenosynovial giant cell tumour\/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors. Eur J Cancer (Oxford, England: 1990). 2015;51(2):210\u20137.","journal-title":"Eur J Cancer (Oxford, England: 1990)."},{"issue":"11","key":"9836_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.autrev.2010.07.001","volume":"9","author":"U Fiocco","year":"2010","unstructured":"Fiocco U, Sfriso P, Lunardi F, et al. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis. Autoimmun Rev. 2010;9(11):780\u20134.","journal-title":"Autoimmun Rev."},{"issue":"5","key":"9836_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1470-2045(18)30143-8","volume":"19","author":"H Gelderblom","year":"2018","unstructured":"Gelderblom H, Cropet C, Chevreau C, et al. Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2018;19(5):639\u201348.","journal-title":"Lancet Oncol."},{"issue":"16","key":"9836_CR26","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1007\/s40265-019-01210-0","volume":"79","author":"YN Lamb","year":"2019","unstructured":"Lamb YN. Pexidartinib: First approval. Drugs. 2019;79(16):1805\u201312.","journal-title":"Drugs."},{"key":"9836_CR27","doi-asserted-by":"crossref","unstructured":"Gelderblom H, Wagner AJ, Tap WD, et al. Long-term outcomes of pexidartinib in tenosynovial giant cell tumors. Cancer. 2020.","DOI":"10.1002\/cncr.33312"},{"issue":"21","key":"9836_CR28","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1158\/1078-0432.CCR-20-0855","volume":"26","author":"KA Autio","year":"2020","unstructured":"Autio KA, Klebanoff CA, Schaer D, et al. Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: a phase I study. Clin Cancer Res. 2020;26(21):5609\u201320.","journal-title":"Clin Cancer Res."},{"key":"9836_CR29","doi-asserted-by":"publisher","unstructured":"Akkari L, Bowman RL, Tessier J, et al. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Sci Transl Med. 2020;12(552):eaaw7843. https:\/\/doi.org\/10.1126\/scitranslmed.aaw7843.","DOI":"10.1126\/scitranslmed.aaw7843"},{"issue":"1","key":"9836_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","volume":"5","author":"MA Cannarile","year":"2017","unstructured":"Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, R\u00fcttinger D. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J Immunother Cancer. 2017;5(1):53.","journal-title":"J Immunother Cancer."},{"issue":"3","key":"9836_CR31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1158\/1078-0432.CCR-19-1486","volume":"26","author":"C Murga-Zamalloa","year":"2020","unstructured":"Murga-Zamalloa C, Rolland DCM, Polk A, et al. Colony-stimulating factor 1 receptor (CSF1R) activates akt\/mtor signaling and promotes t-cell lymphoma viability. Clin Cancer Res. 2020;26(3):690\u2013703.","journal-title":"Clin Cancer Res."},{"issue":"12","key":"9836_CR32","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1158\/1078-0432.CCR-13-2576","volume":"20","author":"PP Patwardhan","year":"2014","unstructured":"Patwardhan PP, Surriga O, Beckman MJ, et al. Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs. Clin Cancer Res. 2014;20(12):3146\u201358.","journal-title":"Clin Cancer Res."},{"issue":"23","key":"9836_CR33","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.1158\/1078-0432.CCR-20-1696","volume":"26","author":"LH Boal","year":"2020","unstructured":"Boal LH, Glod J, Spencer M, et al. Pediatric PK\/PD phase I trial of pexidartinib in relapsed and refractory leukemias and solid tumors including neurofibromatosis type I-related plexiform neurofibromas. Clin Cancer Res. 2020;26(23):6112\u201321.","journal-title":"Clin Cancer Res."},{"issue":"6","key":"9836_CR34","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1095\/biolreprod.102.011734","volume":"68","author":"T Israely","year":"2003","unstructured":"Israely T, Dafni H, Granot D, Nevo N, Tsafriri A, Neeman M. Vascular remodeling and angiogenesis in ectopic ovarian transplants: a crucial role of pericytes and vascular smooth muscle cells in maintenance of ovarian grafts. Biol Reproduct. 2003;68(6):2055\u201364.","journal-title":"Biol Reproduct."},{"issue":"2","key":"9836_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/pros.20225","volume":"64","author":"Y Wang","year":"2005","unstructured":"Wang Y, Revelo MP, Sudilovsky D, et al. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate. 2005;64(2):149\u201359.","journal-title":"Prostate."},{"issue":"1","key":"9836_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1245\/s10434-018-7008-2","volume":"26","author":"KI Votanopoulos","year":"2019","unstructured":"Votanopoulos KI, Mazzocchi A, Sivakumar H, et al. Appendiceal cancer patient-specific tumor organoid model for predicting chemotherapy efficacy prior to initiation of treatment: a feasibility study. Ann Surg Oncol. 2019;26(1):139\u201347.","journal-title":"Ann Surg Oncol."},{"key":"9836_CR37","doi-asserted-by":"publisher","unstructured":"Yin S, Xi R, Wu A, et al. Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci Transl Med. 2020;12(549):eaaz1723. https:\/\/doi.org\/10.1126\/scitranslmed.aaz1723.","DOI":"10.1126\/scitranslmed.aaz1723"},{"key":"9836_CR38","doi-asserted-by":"publisher","unstructured":"Tieu T, Irani S, Bremert KL, et al. Patient-derived prostate cancer explants: a clinically relevant model to assess siRNA-based nanomedicines. Adv Healthc Mater. 2020:e2001594. https:\/\/doi.org\/10.1002\/adhm.202001594.","DOI":"10.1002\/adhm.202001594"},{"key":"9836_CR39","doi-asserted-by":"crossref","unstructured":"Collins A, Miles GJ, Powley IR, et al. Development of a patient-derived explant model for prediction of drug responses in endometrial cancer. Gynecol Oncol. 2020;160(2):557\u201367.","DOI":"10.1016\/j.ygyno.2020.11.033"},{"key":"9836_CR40","doi-asserted-by":"crossref","unstructured":"Miles GJ, Powley I, Mohammed S, et al. Evaluating and comparing immunostaining and computational methods for spatial profiling of drug response in patient-derived explants. Lab Invest. 2020;101(3):396\u2013407.","DOI":"10.1038\/s41374-020-00511-3"},{"key":"9836_CR41","doi-asserted-by":"publisher","unstructured":"Versluis JM, Thommen DS, Blank CU. Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street Approach. J Immunother Cancer. 2020;8(2):e001352. https:\/\/doi.org\/10.1136\/jitc-2020-001352.","DOI":"10.1136\/jitc-2020-001352"},{"issue":"11","key":"9836_CR42","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/ng.3967","volume":"49","author":"U Ben-David","year":"2017","unstructured":"Ben-David U, Ha G, Tseng YY, et al. Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Gen. 2017;49(11):1567\u201375.","journal-title":"Nat Gen."},{"issue":"1","key":"9836_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41588-020-00750-6","volume":"53","author":"XY Woo","year":"2021","unstructured":"Woo XY, Giordano J, Srivastava A, et al. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts. Nat Gen. 2021;53(1):86\u201399.","journal-title":"Nat Gen."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09836-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-09836-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-09836-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T10:07:19Z","timestamp":1632478039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-09836-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,21]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["9836"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-09836-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,21]]},"assertion":[{"value":"31 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}